Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Japan flag Japan · Delayed Price · Currency is JPY
1,478.00
-16.00 (-1.07%)
Mar 9, 2026, 3:30 PM JST
37.49%
Market Cap 43.10B
Revenue (ttm) 51.20B
Net Income (ttm) 2.23B
Shares Out 29.16M
EPS (ttm) 74.32
PE Ratio 19.89
Forward PE 18.53
Dividend 40.00 (2.68%)
Ex-Dividend Date May 28, 2026
Volume 165,700
Average Volume 98,225
Open 1,477.00
Previous Close 1,494.00
Day's Range 1,454.00 - 1,489.00
52-Week Range 970.00 - 1,508.00
Beta 0.28
RSI 65.06
Earnings Date Apr 17, 2026

About Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its nam... [Read more]

Sector Healthcare
Founded 1942
Employees 1,073
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4577
Full Company Profile

Financial Performance

In fiscal year 2025, Daito Pharmaceutical's revenue was 50.64 billion, an increase of 7.99% compared to the previous year's 46.90 billion. Earnings were 1.91 billion, a decrease of -42.09%.

Financial Statements

News

There is no news available yet.